TrialHuman vaccines & immunotherapeutics2025
Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023-February 2024.
Vishal Jain et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.